PLX · Categories · Form 3

PLX - SEC Form 3 initial insider statements

Protalix BioTherapeutics Inc. (DE) (PLX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for PLX

• 44d
  Amendment: New insider Mamlok Gilad claimed ownership of 3,631 shares (SEC Form 3)

  3/A - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 289d
  SEC Form 3 filed by new insider Mamlok Gilad

  3 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 342d
  SEC Form 3 filed by new insider Elze Christian

  3 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 999d
  SEC Form 3 filed by new insider Forster Eliot

  3 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1436d
  SEC Form 3 filed by new insider Ben Zvi Shmuel

  3 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1941d
  SEC Form 3: Ltd. Technologies Pharma Dexcel claimed ownership of 4,556,031 units of Common Stock

  3 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)

Other PLX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends